Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor inFrontiers in medicine · 2021
   Article
2. Discoid Lupus Erythematosus Lesions Associated with Systemic Fluorouracil Agents: A Case Report and Review.Cureus · 2020
   Article
3. Subacute cutaneous lupus erythematosus induced by gemcitabine in 2 patients with pancreatic cancer.JAAD case reports · 2019
   Article
4. Drug-induced subacute cutaneous lupus erythematosus associated with nab-paclitaxel therapy.Current oncology (Toronto, Ont.) · 2013
   Article

Corrections and comments

• Commented on by
  Clinically relevant information about cutaneous lupus erythematosus.2009

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as